scanx.trade

Zydus Lifesciences forms 50-50 JV with Sunshine Healthcare Lanka in Sri Lanka

Zydus Lifesciences logoZydus Lifesciences
Sig3.05Sen+2.12Env0.00Soc0.00Gov+0.83

Zydus Lifesciences signed a Share Subscription and Shareholders’ Agreement on June 26, 2026 to form Zydus Sunshine Lifesciences (Private) Limited with Sunshine Healthcare Lanka, with both partners holding equal stakes and Zydus subscribing 50% equity. Total investment commitment is over USD 20 million for a pharmaceutical facility in Sri Lanka’s Horana Export Processing Zone. Separately, Zydus extinguished 87,30,158 shares bought back via a tender offer, reducing share capital and lifting promoter and promoter group holding to 75.01%.

Coverage (1)

ABOUT

What is Fimmer?

Most feeds treat all company headlines the same. An executive interview, an office closure, stock analysis, and a data breach can sit side by side with no sense of scale. Fimmer ranks coverage by what matters, so important events stand out and signals are prioritised over noise. We cluster related company news and score each story using a range of metrics, so you see the most crucial stories first.

SCORING

What do the scores mean?

Significance (0–10) measures the scale of the real-world impact. Sentiment and ESG (−10 to +10) indicate the tone of the coverage and whether the change relates to environmental, social, or governance factors. Together, these scores help distinguish meaningful developments from routine company news. More information about our scoring methodology can be found on our About page.

DISCOVERY

Explore more on Fimmer

Search more than 10,000 public companies, browse the company index, explore their scores, and read the coverage behind them, with our core features available to everyone for free.

For more advanced features, Pro gives you access to dynamic feeds, custom sorting, and more ways to track the companies that matter to you.

More with Pro